Downregulation of CD73 associates with T cell exhaustion in AML patients
Abstract Background Successful treatment for acute myeloid leukemia (AML) remains challenging. Inhibiting immune checkpoint to enhance anti-tumor response is an attractive strategy for effective leukemia therapeutics. CD73 is a recently recognized immune checkpoint mediator that is highly expressed...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2019-04-01
|
| Saila: | Journal of Hematology & Oncology |
| Gaiak: | |
| Sarrera elektronikoa: | http://link.springer.com/article/10.1186/s13045-019-0728-3 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|